Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dth.13430 http://scihub22266oqcxt.onion/10.1111/dth.13430 32314460!7235502!32314460     free     free     free       Dermatol+Ther 2020 ; 33 (5): e13430 Nephropedia Template TP {{tp|p=32314460|t=2020. Challenges of COVID-19 pandemic for dermatology |pdf=|usr=}}{{32314460}} gab.com Text Challenges of COVID-19 pandemic for dermatology JO: Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32314460 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the pandemic named coronavirus disease 2019 (COVID-19). The disease causes SARS with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least, education in dermatology for students will not be temporarily possible in the classical settings. COVID-19, although not a skin disease, by itself has an immense impact on dermatology. Twit Text FOAVip Challenges of COVID-19 pandemic for dermatology ????Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=32314460 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32314460 #FOAvip English Wikipedia <ref>{{Cite pmid|32314460}}</ref> Challenges of COVID-19 pandemic for dermatology #MMPMID32314460 Wollina U Dermatol Ther 2020[Sep]; 33 (5): e13430 PMID32314460show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the pandemic named coronavirus disease 2019 (COVID-19). The disease causes SARS with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least, education in dermatology for students will not be temporarily possible in the classical settings. COVID-19, although not a skin disease, by itself has an immense impact on dermatology. |*Dermatology[MESH] |*SARS-CoV-2[MESH] |COVID-19/complications/*epidemiology/prevention & control[MESH] |Dermatitis, Occupational/etiology[MESH] |Humans[MESH] |Interleukin-17/physiology[MESH] |Personal Protective Equipment/adverse effects[MESH]Challenges of COVID-19 pandemic for dermatology (epmc).pdf DeepDyve Pubget Overpricing